An illustration of polycystic ovary syndrome, which causes the ovaries to enlarge Science Photo Library / Alamy
We are finally getting to grips with the genetics of polycystic ovary syndrome (PCOS), which could open the door to new treatments.
PCOS, which is thought to affect , disrupts how ovaries function, resulting in at least two of three features: irregular or no periods; raised levels of male sex hormones, including testosterone; and a build-up of immature eggs that look like cysts in the ovaries. As a result, are common with the condition.
Its exact cause is unknown, but PCOS has been linked to changes to the gut microbiome and hormonal imbalances before birth. It also , with studies estimating that about . But so far, researchers had identified only about 25 genetic variants 鈥 involved in the production of sex hormones, like oestrogen and testosterone, and ovarian function 鈥 that explain about 10 per cent of a person’s risk.
To fill this knowledge gap, at Shandong University in Jinan, China, and his colleagues analysed the genomes of more than 440,000 women across China and Europe, 25,000 of whom had been diagnosed with PCOS, while the remainder hadn’t, in the largest genetic analysis of the condition to date.
The team pinpointed 94 genetic variants that seem to influence PCOS risk, 73 of which had not previously been identified. One of the most interesting of these variants occurs in the gene encoding for mitochondrial ribosomal protein S22, which helps mitochondria, the energy-generating parts of cells, to function properly, says Zhao. While prior studies have linked , this is the first look at how genetics may underly this, he says.
Free newsletter
Sign up to Health Check
Expert insight and news on scientific developments in health, nutrition and fitness, every Saturday.
Another newly identified variant affects a protein called sex hormone-binding globulin, which regulates the activity of sex hormones, and is commonly .
Many of the remaining variants influence the function of the ovary鈥檚 granulosa cells 鈥 which produce oestrogen and progesterone, and help eggs develop 鈥 across the menstrual cycle. This supports the idea that genetics drive PCOS , says Zhao.
Overall, the team calculated that the 94 variants explained about 27 per cent of the variation in PCOS risk among the European participants and about 34 per cent of the risk among the Chinese populations.
鈥淭his study is important because it鈥檚 expanding our understanding of the genetic component of the disease,鈥 says at the Karolinska Institute in Sweden. It also highlights the need to include diverse ancestries in genetic studies of PCOS, says Zhao.
In a final analysis, the researchers pinpointed drugs that could correct the pathways affected by the variants they identified. Some of these are already used to treat PCOS, such as clomifene, which stimulates the release of eggs from the ovary, a process disrupted by the condition. The team also found that betaine 鈥 sometimes used to treat the genetic condition homocystinuria, which can cause eye and skeletal problems 鈥 could also benefit those with PCOS. Studies in mice with induced PCOS-like symptoms could explore this as a treatment option, says Zhao.
鈥淭oday treatment is symptom-orientated; there is no drug that can cure PCOS,鈥 says Stener-Victorin. Common therapies include the contraceptive pill to regulate periods, clomifene or the type 2 diabetes drug metformin, which can enhance fertility. But no one treatment is effective for everyone. 鈥淚dentifying clusters of genes that influence PCOS risk can really help us to direct and do more targeted treatment for these women,鈥 she says.
Journal reference:
Nature Genetics
Topics:
